| NLRP3 inflammasome inhibition by MCC950 reduces atherosclerotic lesion development in apolipoprotein E–deficient mice—brief report T van der Heijden, E Kritikou, W Venema, J van Duijn, PJ van Santbrink, ... Arteriosclerosis, thrombosis, and vascular biology 37 (8), 1457-1461, 2017 | 277 | 2017 |
| Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity B Slütter, N Van Braeckel-Budimir, G Abboud, SM Varga, ... Science immunology 2 (7), eaag2031, 2017 | 259 | 2017 |
| Microanatomy of the human atherosclerotic plaque by single-cell transcriptomics MAC Depuydt, KHM Prange, L Slenders, T Örd, D Elbersen, A Boltjes, ... Circulation research 127 (11), 1437-1455, 2020 | 252 | 2020 |
| Lung airway-surveilling CXCR3hi memory CD8+ T cells are critical for protection against influenza A virus B Slütter, LL Pewe, SM Kaech, JT Harty Immunity 39 (5), 939-948, 2013 | 233 | 2013 |
| Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination B Slütter, L Plapied, V Fievez, MA Sande, A des Rieux, YJ Schneider, ... Journal of Controlled Release 138 (2), 113-121, 2009 | 228 | 2009 |
| Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines N Benne, J van Duijn, J Kuiper, W Jiskoot, B Slütter Journal of Controlled Release 234, 124-134, 2016 | 224 | 2016 |
| Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems D Mohanan, B Slütter, M Henriksen-Lacey, W Jiskoot, JA Bouwstra, ... Journal of Controlled Release 147 (3), 342-349, 2010 | 221 | 2010 |
| Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: Nanoparticle characteristics determine quality and strength of the antibody response in mice against … B Slütter, S Bal, C Keijzer, R Mallants, N Hagenaars, I Que, E Kaijzel, ... Vaccine 28 (38), 6282-6291, 2010 | 220 | 2010 |
| PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity AL Silva, PC Soema, B Slütter, F Ossendorp, W Jiskoot Human vaccines & immunotherapeutics 12 (4), 1056-1069, 2016 | 212 | 2016 |
| Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen B Slütter, PC Soema, Z Ding, R Verheul, W Hennink, W Jiskoot Journal of Controlled Release 143 (2), 207-214, 2010 | 186 | 2010 |
| Rational design of nasal vaccines B Slütter, N Hagenaars, W Jiskoot Journal of drug targeting 16 (1), 1-17, 2008 | 158 | 2008 |
| Targeting CD40-induced TRAF6 signaling in macrophages reduces atherosclerosis TTP Seijkens, CM van Tiel, PJH Kusters, D Atzler, O Soehnlein, ... Journal of the American College of Cardiology 71 (5), 527-542, 2018 | 142 | 2018 |
| Towards tailored vaccine delivery: needs, challenges and perspectives JP Amorij, GFA Kersten, V Saluja, WF Tonnis, WLJ Hinrichs, B Slütter, ... Journal of Controlled Release 161 (2), 363-376, 2012 | 138 | 2012 |
| Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles G Du, RM Hathout, M Nasr, MR Nejadnik, J Tu, RI Koning, AJ Koster, ... Journal of Controlled Release 266, 109-118, 2017 | 118 | 2017 |
| Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination RJ Verheul, B Slütter, SM Bal, JA Bouwstra, W Jiskoot, WE Hennink Journal of Controlled Release, 2011 | 113 | 2011 |
| Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations SM Bal, B Slütter, E van Riet, AC Kruithof, Z Ding, GFA Kersten, W Jiskoot, ... Journal of Controlled Release 142 (3), 374-383, 2010 | 109 | 2010 |
| Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant-and site-dependent immunogenicity in mice SM Bal, B Slütter, R Verheul, JA Bouwstra, W Jiskoot European Journal of Pharmaceutical Sciences, 2011 | 108 | 2011 |
| Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination B Slutter, W Jiskoot Journal of Controlled Release 148 (1), 117-121, 2010 | 102 | 2010 |
| PLGA, PLGA-TMC and TMC-TPP Nanoparticles Differentially Modulate the Outcome of Nasal Vaccination by Inducing Tolerance or Enhancing Humoral Immunity C Keijzer, B Slütter, R van der Zee, W Jiskoot, W van Eden, F Broere PLoS ONE 6 (11), e26684, 2011 | 89 | 2011 |
| Adjuvant effect of cationic liposomes and CpG depends on administration route B Slutter, SM Bal, D Zhi, W Jiskoot, JA Bouwstra Journal of Controlled Release, 2011 | 78 | 2011 |
